Steven L. Borzak

Cardiology
5401 S Congress Ave Ste 102
Atlantis, FL 33462

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

After successful catheter ablation for AF, rivaroxaban did not reduce a composite of stroke or systemic embolism vs. aspirin at 36 mo.

After successful catheter ablation for AF, rivaroxaban did not reduce a composite of stroke or systemic embolism vs. aspirin at 36 mo.

Journal: Annals of internal medicine
Published: March 02, 2026

In HF with functional MR, TEER with MitraClip improved HF hospitalization or CV death and health status.

In HF with functional MR, TEER with MitraClip improved HF hospitalization or CV death and health status.

Journal: Annals of internal medicine
Published: December 02, 2024

In HF with secondary MR at high surgical risk, TEER was noninferior to surgery for CV events and reduced safety events at 1 y.

In HF with secondary MR at high surgical risk, TEER was noninferior to surgery for CV events and reduced safety events at 1 y.

Journal: Annals of internal medicine
Published: December 02, 2024

In adults with AMI who are at risk for HF, empagliflozin did not reduce a composite of first HF hospitalization or all-cause death at 18 mo.

In adults with AMI who are at risk for HF, empagliflozin did not reduce a composite of first HF hospitalization or all-cause death at 18 mo.

Journal: Annals of internal medicine
Published: July 01, 2024

In noncardiac thoracic surgery, low-dose colchicine did not reduce AF or myocardial injury after noncardiac surgery at 14 d.

In noncardiac thoracic surgery, low-dose colchicine did not reduce AF or myocardial injury after noncardiac surgery at 14 d.

Journal: Annals of internal medicine
Published: January 01, 2024

Reduced dietary sodium did not reduce clinical events in heart failure.

Reduced dietary sodium did not reduce clinical events in heart failure.

Journal: Annals of internal medicine
Published: August 01, 2022

In patients with MI or high-risk coronary disease, influenza vaccination reduced CV events at 12 mo.

In patients with MI or high-risk coronary disease, influenza vaccination reduced CV events at 12 mo.

Journal: Annals of internal medicine
Published: February 28, 2022

In patients with stable CVD receiving statins, evolocumab reduced acute arterial events across all vascular territories.

In patients with stable CVD receiving statins, evolocumab reduced acute arterial events across all vascular territories.

Journal: Annals of internal medicine
Published: January 31, 2022

After PCI and short-term DAPT, P2Y12 inhibitors alone vs. ongoing DAPT reduce major bleeding; CV events do not differ.

After PCI and short-term DAPT, P2Y12 inhibitors alone vs. ongoing DAPT reduce major bleeding; CV events do not differ.

Journal: Annals of internal medicine
Published: October 19, 2020

Pantoprazole did not reduce risk for a composite of upper gastrointestinal events in stable arterial disease.

Pantoprazole did not reduce risk for a composite of upper gastrointestinal events in stable arterial disease.

Journal: Annals of internal medicine
Published: October 15, 2019

After PCI with 2nd-generation DESs for STEMI, dual-antiplatelet therapy for 6 mo was noninferior to 12 mo.

After PCI with 2nd-generation DESs for STEMI, dual-antiplatelet therapy for 6 mo was noninferior to 12 mo.

Journal: Annals of internal medicine
Published: January 15, 2019

In stable CVD, rivaroxaban plus aspirin reduced CV events and increased bleeding compared with aspirin alone.

In stable CVD, rivaroxaban plus aspirin reduced CV events and increased bleeding compared with aspirin alone.

Journal: Annals of internal medicine
Published: November 22, 2017
Showing 1-12 of 20

Last Updated: 09/26/2026